Evaluating treatment options for low-risk thyroid cancer
Preference-Based Treatment Valuation in Low-Risk Thyroid Cancer
This study is looking at how different treatment options for low-risk thyroid cancer, like active monitoring or surgery, affect patients' experiences and preferences, so we can better understand what matters most to you when choosing a treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10947007 on NIH RePORTER |
What this research studies
This research investigates the value of different treatment options for patients with low-risk thyroid cancer, specifically focusing on papillary thyroid microcarcinoma. It aims to understand patients' preferences and perceptions regarding their treatment experiences, which can vary significantly despite similar survival outcomes. By using patient-reported measures, the study will estimate the health state utilities associated with various therapies, including active surveillance and surgical options. The findings will help inform a cost-effectiveness model that compares these treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with low-risk papillary thyroid microcarcinoma who are considering treatment options.
Not a fit: Patients with high-risk thyroid cancer or those who have already undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help tailor treatment options for low-risk thyroid cancer patients based on their preferences, potentially improving their quality of life.
How similar studies have performed: Previous research has shown that understanding patient preferences can significantly impact treatment decisions and outcomes, suggesting this approach has potential for success.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Hu, Yinin — University of Maryland Baltimore
- Study coordinator: Hu, Yinin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.